The favorable characteristics of anti-CMV T cells, including their robust cytotoxic activity, persistence, and capacity to home and remain functional in an immunosuppressive tumor microenvironment, have prompted their use in CD19-CAR T cell approaches [25]. Here, CD19 is linked to neoplasm.